Orajel, Other Benzocaine Teething Products May Cause Fatal Blood Disorder: FDA
The FDA urges parents not to use benzocaine products to alleviate infant teething due to the risk of a rare and potentially fatal blood disorder.
The FDA urges parents not to use benzocaine products to alleviate infant teething due to the risk of a rare and potentially fatal blood disorder.
The FDA faces a lawsuit by Public Citizen, who says the agency has unlawfully failed to act on a 2014 petition to remove benzocaine-based teething products from the market due…
The FDA warns that the use of prescription oral viscous lidocaine to treat teething pain can lead to injury or death for infants and small children.